Skye Bioscience

0 followers

‌

Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Punit Dhillon

CEO

Punit Dhillon

Collapse

Kaitlyn Arsenault

Chief Financial Officer

Tu Diep

Chief Development Officer

Chris Twitty

Chief Scientific Officer

Karam Takhar

VP, Corporate Development & Investor Relations

Teams

Advisory & Clinical Team

6 members

Directors

5 members

Leadership Team

3 members

Similar companies

Mirum Pharmaceuticals

3 followers

Bristol-Myers Squibb

163 followers

Viatris

30 followers

Omnicell

20 followers

Syneos Health

16 followers

Karyopharm Therapeutics

12 followers

Agios Pharmaceuticals

5 followers

Parexel

4 followers

AbbVie

149 followers

Charlie Health

3 followers

PPD

15 followers

Discover companies